Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an essential electrolyte used to prevent or treat hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing * **Oral:** * **Prevention:** 20 mEq (1.5 g) once daily. * **Treatment:** 40-100 mEq (3-7.5 g) daily, divided into 2-5 doses. Maximum daily dose generally not to exceed 200 mEq. * **Intravenous:** Dosing is highly individualized based on serum potassium levels and clinical status. Generally administered in a dextrose or saline solution. * **Mild hypokalemia (3.1-3.9 mEq/L):** 10-20 mEq over several hours. * **Moderate hypokalemia (2.5-3.0 mEq/L):** 20-40 mEq over several hours. * **Severe hypokalemia (<2.5 mEq/L):** Up to 40 mEq per dose, potentially requiring continuous infusion or more frequent administration. * **Maximum infusion rate:** Generally **10-20 mEq/hour** peripherally and up to **40 mEq/hour** centrally, but this can be adjusted based on ECG monitoring and patient tolerance. Extreme caution and continuous cardiac monitoring are required for rates >20 mEq/hour. * **Maximum concentration:** Generally **40 mEq/L** peripherally and up to **80 mEq/L** centrally. Higher concentrations may be used in emergencies with central access and continuous monitoring. ## Pediatric Dosing Dosing is based on weight and serum potassium levels, and is highly individualized. Consult specific pediatric guidelines or a pediatric specialist. General guidelines: * **Maintenance:** 1-2 mEq/kg/day orally, divided into 1-2 doses. Do not exceed 3 mEq/kg/day. * **Treatment:** May require higher doses, administered orally or intravenously, under close monitoring. * **Intravenous infusion rate:** Generally **0.5-1 mEq/kg/hour**, not to exceed 20 mEq/hour. Higher rates may be used in emergencies with continuous cardiac monitoring. * **Maximum concentration:** Typically **40 mEq/L** (IV). ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Potassium accumulation can lead to hyperkalemia. Dose reductions or avoidance may be necessary. Monitor electrolytes closely. * **Adrenal Insufficiency:** Patients are at increased risk of hyperkalemia. ## Contraindications * Severe renal impairment. * Conditions where hyperkalemia is present or likely to occur (e.g., untreated Addison's disease, severe burns, crush injuries, extensive tissue breakdown, certain myopathies). * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea, flatulence. Oral formulations can cause gastrointestinal irritation or ulceration, especially if not taken with sufficient fluid. * **Cardiovascular:** Arrhythmias, cardiac arrest (especially with rapid IV infusion or hyperkalemia). * **Neuromuscular:** Weakness, paresthesias, paralysis. * **Other:** Hyperkalemia (potentially life-threatening). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors and Angiotensin II Receptor Blockers (ARBs):** Can increase serum potassium levels, increasing the risk of hyperkalemia. * **NSAIDs:** May reduce the renal excretion of potassium, increasing the risk of hyperkalemia. * **Heparin:** May impair potassium excretion and increase the risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase the toxicity of digoxin; hypokalemia can increase the risk of arrhythmias in patients receiving digoxin. ## Monitoring * **Serum potassium levels:** Essential before and during therapy, especially with IV administration. * **Renal function:** Monitor BUN and creatinine. * **ECG:** Particularly important during rapid IV infusions or in patients with known cardiac issues or risk factors for hyperkalemia. * **Signs and symptoms of hypokalemia and hyperkalemia.** ## Clinical Pearls * Oral potassium chloride should be taken with meals and a full glass of water to minimize gastrointestinal irritation. * Dilute concentrated intravenous potassium chloride solutions significantly before administration. * Never administer potassium chloride undiluted as an IV bolus. * The goal of potassium replacement is to restore normal serum potassium levels, not to achieve a specific serum potassium concentration immediately unless in a critical care setting with close monitoring. *** **Disclaimer:** This information is intended for clinical use and does not replace professional judgment. Always consult the most current prescribing information, institutional protocols, and patient-specific factors before making any clinical decisions.